PLAY PODCASTS
πŸͺ™ Double Trouble or Dual Protection? πŸ’ŠπŸ’ŠπŸ›‘οΈ  Ticagrelor and Aspirin After CABGβ€”What Did We Learn?

πŸͺ™ Double Trouble or Dual Protection? πŸ’ŠπŸ’ŠπŸ›‘οΈ Ticagrelor and Aspirin After CABGβ€”What Did We Learn?

Dr RR Baliga's "Got Knowledge Doc" Podkast

October 30, 20254m 14s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

🧠 TACSI Trial in NEJM (Sep 2025) challenges the status quo on dual antiplatelet therapy after CABG for ACS!

πŸ‘¨β€βš•οΈ 2201 patients across 5 Nordic countries

πŸ’Š Ticagrelor + Aspirin β‰  better outcomes vs Aspirin alone

πŸ“‰ No reduction in death, MI, stroke, or revascularization

🩸 But bleeding (4.9% vs 2.0%) & dyspnea (18.2% vs 6.4%) increased

πŸ“š Guidelines may need rethinking.

πŸ“– Jeppsson A et al. N Engl J Med. 2025; DOI: 10.1056/NEJMoa2508026

#TACSI #Cardiology #CABG #DAPT #ACS #NEJM #PrecisionMedicine #RCT #BleedingRisk #ClinicalTrials